|
|
|
Corporate Profile: XenoPort
| Summary: |
XenoPort, Inc.
is an early-stage biopharmaceutical company that is
a leader in development and application of new technologies
to enhance the bioavailability of drugs by exploiting
the function of specific proteins involved in active
transport of molecules into and through cells. |
| Address (HQ):
|
3410 Central Expressway
Santa Clara, CA 95051 |
| Phone #'s (HQ): |
Main |
(408) 616-7200 |
| Human Resources |
not known |
| Investor Relations |
(408) 616-7200 |
| Fax #'s (HQ): |
Main |
(408) 616-7210 |
| Human Resources |
(408) 616-7210 |
| Investor Relations |
not known |
| Financial
information: |
| XNPT |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
